HIMS Q1 2026 Earnings Significant EPS Miss as Loss Deepens Stock Declines Maximus MMS Q1 2026 Earnings EPS Beats Estimates Stock Slightly Down Huron Consulting Group Q1 2026 Earnings EPS Surpasses Estimates by 58 JCAP Q1 2026 Earnings EPS Beat Defies Market Expectations Despite Slight Stock Dip CCNEP Q1 2026 Earnings EPS Beats Estimates Preferred Stock Shows Resilience VENU Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Undisclosed AMSF Q1 2026 Earnings EPS Misses Estimates as Stock Declines NeoGenomics NEO Q1 2026 Earnings EPS Beats Estimates by 389 Stock Gains Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations THCH Q4 2025 Earnings Negative EPS Reported as Stock Gains 285 TOI Q1 2026 Earnings Narrowing Losses Surprises Street Shares Edge Higher Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues NIC Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Reaction